Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Chromadex Corp CDXC

Technology Scientific & Technical Instruments
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished... see more

Recent & Breaking News (NDAQ:CDXC)

ChromaDex Corporation Reports Third Quarter 2022 Financial Results

Business Wire November 2, 2022

ChromaDex to Report Third Quarter Financial Results on Wednesday, November 2, 2022

Business Wire October 26, 2022

ChromaDex's Tru Niagen® Won the "Most Popular Brand of the Year Award" at China International Natural Health & Nutrition Expo's (NHNE) Prestigious Nutrition Planet Awards

Business Wire October 24, 2022

ChromaDex and Nestlé Health Science Announce New Niagen® Commercial Supply Agreement and $5 Million Investment

Business Wire October 11, 2022

ChromaDex Shares Promising Findings from Clinical Study Showcasing ​​the Safety and Tolerability of Nicotinamide Riboside (NR) in Heart Failure With Reduced Ejection Fraction

Business Wire October 4, 2022

ChromaDex Finalizes Commercial Joint-Venture in Asia and Announces $3.1 Million Private Placement of Common Stock

Business Wire October 3, 2022

Sinopharm Xingsha to Introduce ChromaDex's Tru Niagen® at Major Mainland China Trade Show, China International Natural Health & Nutrition Expo (NHNE)

Business Wire September 19, 2022

ChromaDex Announces Partnership with MyPharma2Go Corporation for Cross-Border Sales of Tru Niagen® and Tru Niagen® PRO into Brazil

Business Wire September 1, 2022

Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer

PR Newswire August 24, 2022

Thorne Research, Inc. Loses Patent Challenge Decision, Upholding ChromaDex's Intellectual Property Held Under Exclusive License From Dartmouth College

Business Wire August 15, 2022

ChromaDex Corporation Reports Second Quarter 2022 Financial Results

Business Wire August 10, 2022

ChromaDex to Report Second Quarter 2022 Financial Results on Wednesday, August 10, 2022

Business Wire August 2, 2022

ChromaDex To Host Key Opinion Leader Webinar on the Transforming Benefits of Nicotinamide Riboside (NR)

Business Wire July 7, 2022

ChromaDex to Present at American Society for Nutrition (ASN), International Society of Sports Nutrition (ISSN), and Federation of American Societies for Experimental Biology (FASEB)

Business Wire June 15, 2022

ChromaDex Signs Sinopharm Xingsha Agreement to Accelerate Cross-Border Sales of Tru Niagen® into Mainland China

Business Wire June 10, 2022

ChromaDex to Present at the Oppenheimer's 22nd Annual Consumer Growth and E-Commerce Conference

Business Wire June 7, 2022

ChromaDex Partners with Juvenis for Cross-Border Sales of Tru Niagen® into South Korea

Business Wire June 2, 2022

ChromaDex to Present at the LD Micro Invitational

Business Wire June 1, 2022

ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China

Business Wire May 19, 2022

ChromaDex Wins International 2022 European NutraIngredients Award for Developing the Science Behind Niagen®

Business Wire May 17, 2022